Xunyao Biotechnology
About:
Xunyao Biotech is a cutting-edge medication development company focused on coagulation and fibrosis.
Top Investors: Shanghai Biomedical Industrial Equity Investment Fund, Longpan Investment
Description:
Xunyao Biotech is a cutting-edge medication development company focused on coagulation and fibrosis. Xunyao Biotech specializes on the research and development of novel pharmaceuticals in the disciplines of coagulation and fibrosis.
Total Funding Amount:
200M CNY
Headquarters Location:
Shanghai, Shanghai, China
Founded Date:
2021-01-01
Founders:
Number of Employees:
11-50
Last Funding Date:
2024-01-10
IPO Status:
Private
Industries:
© 2025 bioDAO.ai